HealthQuill cancer therapy
Modifi Biosciences, Inc., a Yale University spinout company formed in 2021, has been acquired by Merck & Co. for about $1.3 billion to gain access to therapies that aim to kill cancer cells by modifying cancer DNA selectively.
Drugs Health Pharma

Merck acquires Yale University spinout Modifi Biosciences for up to $1.3 billion

Modifi Biosciences, Inc., a Yale University spinout company formed in 2021, has been acquired by Merck & Co. for about $1.3 billion to.

Read More
blood thinners
Drugs Health Medical

Strategy of genetic shielding of blood cells helps eradicate blood cancer

HQ Team July 18, 2024: In a reversal strategy in the war against cancer, researchers are now aiming to genetically cloak healthy cells.

Read More
Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which in future can fight cancer and diabetes.
Drugs Health Medical

Key metabolite’s role in DNA repair will help cancer treatment

HQ team November 3, 2023: Researchers at Michigan Medicine, University of Michigan, have discovered a key metabolite’s role in regulating DNA repair processes,.

Read More